• Explore /
  • Poster
  • / TENERGY: Multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy with 5-FU plus cisplatin in patients with locally advanced esophageal squamous cell carcinoma.

TENERGY: Multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy with 5-FU plus cisplatin in patients with locally advanced esophageal squamous cell carcinoma.

Abstract Poster

Authors

null

Hideaki Bando

Aichi Cancer Center Hospital, Nagoya, Japan

Hideaki Bando , Daisuke Kotani , Takahiro Tsushima , Hiroki Hara , Shigenori Kadowaki , Ken Kato , Keisho Chin , Kensei Yamaguchi , Shun-ichiro Kageyama , Hidehiro Hojo , Masashi Wakabayashi , Miki Fukutani , Yosuke Togashi , Nozomu Fuse , Hiroyoshi Nishikawa , Takashi Kojima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

UMIN000034373

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS4141)

DOI

10.1200/JCO.2019.37.15_suppl.TPS4141

Abstract #

TPS4141

Poster Bd #

246a

Abstract Disclosures

Similar Posters

First Author: Hideaki Bando

First Author: Helen J. Ross

First Author: Jing Huang

First Author: Jaume Capdevila